Birzeit Pharmaceuticals Company (PEX:BPC)
Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
3.650
0.00 (0.00%)
At close: Jul 28, 2026

PEX:BPC Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
12.5911.955.186.127.9512.08
Depreciation & Amortization
1.411.411.421.51.661.66
Loss (Gain) From Sale of Assets
-0-00-0.05-0.05-0.16
Asset Writedown & Restructuring Costs
----0.69-0.27
Loss (Gain) From Sale of Investments
0.24-0.041.631.24-0.88-2.03
Provision & Write-off of Bad Debts
0.210.21-0.850.210.17
Other Operating Activities
2.021.8701.731.082.21
Change in Accounts Receivable
-18.23-10.36-5.78-0.04-5.21-10.55
Change in Inventory
-1.31-0.931.3-0.93-0.550.54
Change in Accounts Payable
-0.56-0.564.67---
Change in Other Net Operating Assets
6.17-1.21-1.461.770.3-0.01
Operating Cash Flow
2.532.346.9612.165.213.65
Operating Cash Flow Growth
-65.85%-66.44%-42.79%133.66%42.70%-35.22%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.64-2.33-1.52-3.33-3.59-0.93
Sale of Property, Plant & Equipment
00.02--0.05-
Cash Acquisitions
-0.04--0.02-0.13--0.01
Divestitures
0.090.09--0.01-
Sale (Purchase) of Real Estate
---0.32-0.96
Investment in Securities
-1.07-0.71-3.49-3.863.48-1.13
Investing Cash Flow
-2.66-2.94-5.04-7.01-0.05-1.11

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
----1.22-0.82-1.17
Net Debt Issued (Repaid)
1.2---1.22-0.82-1.17
Issuance of Common Stock
--00--
Repurchase of Common Stock
-0.02-0.01---0.08-0.01
Common Dividends Paid
-1.94-1.94-1.94-3.88-1.94-2.85
Financing Cash Flow
-0.75-1.94-1.94-5.09-2.84-4.03

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
0.510.5-0.020.05-0.450.07
Net Cash Flow
-0.36-2.05-0.040.111.86-1.42

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
0.8905.438.831.622.72
Free Cash Flow Growth
-80.95%-99.93%-38.45%446.04%-40.51%-47.00%
Free Cash Flow Margin
1.81%0.01%13.37%20.47%3.44%5.98%
Free Cash Flow Per Share
0.02-0.140.230.040.07
Levered Free Cash Flow
-4.37-4.824.765.21-0.98-1.17
Unlevered Free Cash Flow
-4.34-4.794.785.27-0.91-1.04

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
0.020.020.030.030.03-
Change in Working Capital
-13.94-13.06-1.280.79-5.46-10.02